Literature DB >> 29296900

DNA and factor VII-activating protease protect against the cytotoxicity of histones.

Gerben Marsman1, Helen von Richthofen1, Ingrid Bulder1, Florea Lupu2, Jan Hazelzet3, Brenda M Luken1, Sacha Zeerleder1,4.   

Abstract

Circulating histones have been implicated as major mediators of inflammatory disease because of their strong cytotoxic effects. Histones form the protein core of nucleosomes; however, it is unclear whether histones and nucleosomes are equally cytotoxic. Several plasma proteins that neutralize histones are present in plasma. Importantly, factor VII-activating protease (FSAP) is activated upon contact with histones and subsequently proteolyzes histones. We aimed to determine the effect of FSAP on the cytotoxicity of both histones and nucleosomes. Indeed, FSAP protected against histone-induced cytotoxicity of cultured cells in vitro. Upon incubation of serum with histones, endogenous FSAP was activated and degraded histones, which also prevented cytotoxicity. Notably, histones as part of nucleosome complexes were not cytotoxic, whereas DNA digestion restored cytotoxicity. Histones in nucleosomes were inefficiently cleaved by FSAP, which resulted in limited cleavage of histone H3 and removal of the N-terminal tail. The specific isolation of either circulating nucleosomes or free histones from sera of Escherichia coli challenged baboons or patients with meningococcal sepsis revealed that histone H3 was present in the form of nucleosomes, whereas free histone H3 was not detected. All samples showed signs of FSAP activation. Markedly, we observed that all histone H3 in nucleosomes from the patients with sepsis, and most histone H3 from the baboons, was N-terminally truncated, giving rise to a similarly sized protein fragment as through cleavage by FSAP. Taken together, our results suggest that DNA and FSAP jointly limit histone cytotoxicity and that free histone H3 does not circulate in appreciable concentrations in sepsis.

Entities:  

Year:  2017        PMID: 29296900      PMCID: PMC5728637          DOI: 10.1182/bloodadvances.2017010959

Source DB:  PubMed          Journal:  Blood Adv        ISSN: 2473-9529


  59 in total

1.  Factor VII-activating protease is activated in multiple trauma patients and generates anaphylatoxin C5a.

Authors:  Sandip M Kanse; Andrea Gallenmueller; Sacha Zeerleder; Femke Stephan; Olivier Rannou; Stephanie Denk; Michael Etscheid; Guenter Lochnit; Marcus Krueger; Markus Huber-Lang
Journal:  J Immunol       Date:  2012-02-03       Impact factor: 5.422

2.  Isolation of histones and nucleosome cores from mammalian cells.

Authors:  G R Schnitzler
Journal:  Curr Protoc Mol Biol       Date:  2001-05

3.  Nucleosomes in serum of patients with benign and malignant diseases.

Authors:  S Holdenrieder; P Stieber; H Bodenmüller; M Busch; G Fertig; H Fürst; A Schalhorn; N Schmeller; M Untch; D Seidel
Journal:  Int J Cancer       Date:  2001-03-20       Impact factor: 7.396

4.  Reaction patterns of monoclonal antibodies to DNA.

Authors:  R J Smeenk; K Brinkman; H G van den Brink; A A Westgeest
Journal:  J Immunol       Date:  1988-06-01       Impact factor: 5.422

5.  Circulating plasma levels of nucleosomes in patients with systemic lupus erythematosus: correlation with serum antinucleosome antibody titers and absence of clear association with disease activity.

Authors:  Z Amoura; J C Piette; H Chabre; P Cacoub; T Papo; B Wechsler; J F Bach; S Koutouzov
Journal:  Arthritis Rheum       Date:  1997-12

6.  Clearance of human factor XIa-inhibitor complexes in rats.

Authors:  W A Wuillemin; W K Bleeker; J Agterberg; G Rigter; H ten Cate; C E Hack
Journal:  Br J Haematol       Date:  1996-06       Impact factor: 6.998

7.  Histones from dying renal cells aggravate kidney injury via TLR2 and TLR4.

Authors:  Ramanjaneyulu Allam; Christina Rebecca Scherbaum; Murthy Narayana Darisipudi; Shrikant R Mulay; Holger Hägele; Julia Lichtnekert; Jan Henrik Hagemann; Khader Valli Rupanagudi; Mi Ryu; Claudia Schwarzenberger; Bernd Hohenstein; Christian Hugo; Bernd Uhl; Christoph A Reichel; Fritz Krombach; Marc Monestier; Helen Liapis; Kristin Moreth; Liliana Schaefer; Hans-Joachim Anders
Journal:  J Am Soc Nephrol       Date:  2012-06-07       Impact factor: 10.121

8.  Circulating Histones Are Major Mediators of Cardiac Injury in Patients With Sepsis.

Authors:  Yasir Alhamdi; Simon T Abrams; Zhenxing Cheng; Shengjie Jing; Dunhao Su; Zhiyong Liu; Steven Lane; Ingeborg Welters; Guozheng Wang; Cheng-Hock Toh
Journal:  Crit Care Med       Date:  2015-10       Impact factor: 7.598

9.  Histone H3.3 and its proteolytically processed form drive a cellular senescence programme.

Authors:  Luis F Duarte; Andrew R J Young; Zichen Wang; Hsan-Au Wu; Taniya Panda; Yan Kou; Avnish Kapoor; Dan Hasson; Nicholas R Mills; Avi Ma'ayan; Masashi Narita; Emily Bernstein
Journal:  Nat Commun       Date:  2014-11-14       Impact factor: 14.919

10.  Extracellular histone release in response to traumatic injury: implications for a compensatory role of activated protein C.

Authors:  Matthew E Kutcher; Jun Xu; Ryan F Vilardi; Coral Ho; Charles T Esmon; Mitchell Jay Cohen
Journal:  J Trauma Acute Care Surg       Date:  2012-12       Impact factor: 3.313

View more
  9 in total

Review 1.  Neutrophils: back in the thrombosis spotlight.

Authors:  Denis F Noubouossie; Brandi N Reeves; Brian D Strahl; Nigel S Key
Journal:  Blood       Date:  2019-03-21       Impact factor: 22.113

2.  Extracellular Histones Trigger Disseminated Intravascular Coagulation by Lytic Cell Death.

Authors:  Yan Zhang; Congqing Wu; Lan Li; Ankit Pandeya; Guoying Zhang; Jian Cui; Daniel Kirchhofer; Jeremy P Wood; Susan S Smyth; Yinan Wei; Zhenyu Li
Journal:  Int J Mol Sci       Date:  2022-06-18       Impact factor: 6.208

3.  VEGF-A-Cleavage by FSAP and Inhibition of Neo-Vascularization.

Authors:  Özgür Uslu; Joerg Herold; Sandip M Kanse
Journal:  Cells       Date:  2019-11-06       Impact factor: 6.600

Review 4.  Mechanisms of Immunothrombosis by SARS-CoV-2.

Authors:  María Teresa Hernández-Huerta; Alma Dolores Pérez-Santiago; Laura Pérez-Campos Mayoral; Luis Manuel Sánchez Navarro; Francisco Javier Rodal Canales; Abraham Majluf-Cruz; Carlos Alberto Matias-Cervantes; Eduardo Pérez-Campos Mayoral; Carlos Romero Díaz; Gabriel Mayoral-Andrade; Margarito Martínez Cruz; Judith Luna Ángel; Eduardo Pérez-Campos
Journal:  Biomolecules       Date:  2021-10-20

5.  Ex Vivo and In Vitro Analysis Identify a Detrimental Impact of Neutrophil Extracellular Traps on Eye Structures in Equine Recurrent Uveitis.

Authors:  Leonie Fingerhut; Leyla Yücel; Katrin Strutzberg-Minder; Maren von Köckritz-Blickwede; Bernhard Ohnesorge; Nicole de Buhr
Journal:  Front Immunol       Date:  2022-02-10       Impact factor: 7.561

6.  Identification of a Phage Display-Derived Peptide Interacting with the N-Terminal Region of Factor VII Activating Protease (FSAP) Enables Characterization of Zymogen Activation.

Authors:  Sebastian Berge-Seidl; Nis Valentin Nielsen; Armando A Rodriguez Alfonso; Michael Etscheid; Sai Priya Sarma Kandanur; Bengt Erik Haug; Maria Stensland; Bernd Thiede; Merve Karacan; Nico Preising; Sebastian Wiese; Ludger Ständker; Paul J Declerck; Geir Åge Løset; Sandip M Kanse
Journal:  ACS Chem Biol       Date:  2022-09-07       Impact factor: 4.634

Review 7.  Biology, role and therapeutic potential of circulating histones in acute inflammatory disorders.

Authors:  Peter Szatmary; Wei Huang; David Criddle; Alexei Tepikin; Robert Sutton
Journal:  J Cell Mol Med       Date:  2018-08-07       Impact factor: 5.310

8.  Genome-wide analysis of genetic determinants of circulating factor VII-activating protease (FSAP) activity.

Authors:  M Olsson; T M Stanne; A Pedersen; E Lorentzen; E Kara; A Martinez-Palacian; N P Rønnow Sand; A F Jacobsen; P M Sandset; J J Sidelmann; G Engström; O Melander; S M Kanse; C Jern
Journal:  J Thromb Haemost       Date:  2018-08-24       Impact factor: 5.824

Review 9.  The role of endothelial shear stress on haemodynamics, inflammation, coagulation and glycocalyx during sepsis.

Authors:  Florea Lupu; Gary Kinasewitz; Kenneth Dormer
Journal:  J Cell Mol Med       Date:  2020-09-19       Impact factor: 5.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.